← Open Payments lookup

GINA VALENTE-MOORE: Open Payments

NPI 1336337484 · JAMESTOWN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$11,016 in 76 payments from 14 companies in 2025. Trend: 2023 $6,039 · 2024 $7,285 · 2025 $11,016

Speaker / faculty: $5,110Travel & lodging: $3,641Food & beverage: $2,265
CompanyPaymentsAmount
Gilead Sciences, Inc.27$9,615
ABBVIE INC.22$696
Corcept Therapeutics5$186
Janssen Biotech, Inc.5$120
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$105
Novo Nordisk Inc2$53
Vanda Pharmaceuticals Inc.2$52
Aimmune Therapeutics, Inc.2$49
GENZYME CORPORATION1$36
Lilly USA, LLC1$25

Products named: Epclusa, RINVOQ, MAVYRET, SKYRIZI, Korlym, TREMFYA, XIFAXAN, HETLIOZ.

Industry payments across CA — which companies pay providers there.